Tag: opioid

59 posts found

Clinical Insights

Interstate Variation and Trends in Workers’ Comp Drug Payments

A new flash report from the WCRI highlights trends in drug utilization.

Medmonitor

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.

Clinical Insights

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.

Opioid Developments

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Opioid Developments

Purdue, OxyContin Manufacturer, Loses Federal Case and Will Shut Down

The drug manufacturer is pleading guilty and paying out billions.

Medmonitor

FDA Approves Two New Opioids

Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.

Medmonitor

FDA Issues Naloxone Recommendations for Opioids and OUD Drugs

The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.

This Month's Must Read

Overcoming Obstacles to Patient Recovery Amid a Global Pandemic

Healthesystems’ VP of Clinical Services addresses COVID-19 disruptions to workers’ comp, along with helpful strategies

Clinical Insights

American Medical Association Publishes Opioid Task Force Report

AMA hopes to shift from a crisis-reaction framework to a more holistic model that prevents overdose while helping pain patients receive care.

Clinical Insights

American Medical Association Asks CDC to Revise Opioid Guidelines

The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.

This Month's Must Read

Growing Pains: The Shift from Opioids to Other Pain Therapies

With opioid utilization decreasing, what concerns do other pain therapies pose?

Clinical Insights

How Declining Opioid Use Impacts Claims and Outcomes

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

Clinical Insights

HHS Publishes Opioid Tapering and Discontinuation Guideline

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Opioid Developments

The Economic Impact of Non-Medical Opioid Use

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

Medmonitor

FDA Postpones Opioid Approval Decision

NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.

1 2 3 4 Next